Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA.
Transplantation. 2024 Jul 1;108(7):1524-1531. doi: 10.1097/TP.0000000000004847. Epub 2023 Dec 5.
Through the effective targeting of the adaptive immune system, solid organ transplantation became a life-saving therapy for organ failure. However, beyond 1 y of transplantation, there is little improvement in transplant outcomes. The adaptive immune response requires the activation of the innate immune system. There are no modalities for the specific targeting of the innate immune system involvement in transplant rejection. However, the recent discovery of innate allorecognition and innate immune memory presents novel targets in transplantation that will increase our understanding of organ rejection and might aid in improving transplant outcomes. In this review, we look at the latest developments in the study of innate allorecognition and innate immune memory in transplantation.
通过对适应性免疫系统的有效靶向治疗,实体器官移植成为治疗器官衰竭的救命疗法。然而,移植后超过 1 年,移植效果几乎没有改善。适应性免疫反应需要先天免疫系统的激活。目前还没有针对移植排斥中先天免疫系统参与的特定靶向治疗方法。然而,最近发现的先天同种异体识别和先天免疫记忆为移植带来了新的靶点,这将增加我们对器官排斥的理解,并可能有助于改善移植效果。在这篇综述中,我们探讨了移植中先天同种异体识别和先天免疫记忆研究的最新进展。